US 11866742
Fusion proteins comprising enzyme replacement therapy enzymes
granted A61KA61K38/00A61K47/68
Quick answer
US patent 11866742 (Fusion proteins comprising enzyme replacement therapy enzymes) held by DENALI THERAPEUTICS INC. expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- DENALI THERAPEUTICS INC.
- Grant date
- Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61K, A61K38/00, A61K47/68, A61P, A61P3/00